P-714. Symptoms Associated with High Viral Loads of Common Cold Coronaviruses in Hematopoietic Cell Transplantation Recipients
Authors: Ogimi Chikara , Abukar Faduma A , waghmare Alpana , Campbell Angela P , Jerome Keith R , Milano Filippo , Cheng Guang-Shing , Englund Janet A , Boeckh Michael J 
Published: January 2025

Abstract

Background
Limited data exist on the association between specific symptoms and viral loads of common cold coronavirus (ccCOV). We investigated this potential association in allogeneic hematopoietic cell transplant (HCT) recipients.Figure 1.Proportion of sampling time points with each symptom

Methods
Four hundred seventy-one children and adults were prospectively followed with weekly symptom questionnaires through one year after allogeneic HCT at the Fred Hutchinson Cancer Center (12/2005-2/2010). Multiplex PCR for 11 respiratory viruses was performed on combined nasal wash and throat swab samples collected weekly through day 100 post-HCT, and then every three months or if symptoms were present through one-year post-HCT. Positive samples were evaluated for viral loads with quantitative real-time PCR (copies/ml). We included time points with the detection of ccCOV only and corresponding 15-point symptom survey data available post-HCT. To assess the association between specific symptoms and viral loads, the Mann-Whitney or Jonckheere-Terpstra tests were used to compare 2 or &gt;2 groups for continuous variables, respectively.Figure 2.Symptoms associated with higher viral loads

Results
Among 6,276 samples tested, 251 samples (79 patients) were positive for ccCoV. One hundred thirty-six sampling time points (52 patients) met the inclusion criteria. The proportion of sample time points with each symptom present is shown in Figure 1. When we compared viral loads with the presence of each of the 15 symptoms, higher viral loads were associated with the presence of four respiratory tract symptoms (rhinorrhea, sneezing, sore throat, and coughing) and one systemic symptom (diarrhea) (p&lt; 0.01 for each) (Figure 2). Viral loads appeared to increase with increasing number of respiratory tract symptoms (p&lt; 0.001) (Figure 3).Figure 3.Viral loads compared with the number of respiratory tract symptoms

Conclusion
The presence of specific respiratory tract symptoms is associated with higher viral loads of ccCOV in the upper respiratory tract in allogeneic HCT recipients. The association with diarrhea suggests the possibility of fecal shedding, but this was not evaluated in our study. Patients with specific symptoms may be more likely to transmit virus given their higher viral loads. Studies of these associations for other respiratory viruses are warranted.

Disclosures
Chikara Ogimi, MD, PhD, AstraZeneca: Honoraria|bioMerieux Japan Ltd.: Honoraria|ELSEVIER: Honoraria|KYORIN: Honoraria|Miyarisan: Honoraria|MSD: Honoraria|NOVARTIS: Honoraria|Pfizer: Honoraria Alpana waghmare, MD, Allovir: Grant/Research Support|Ansun Biopharma: Grant/Research Support|GlaxoKlineSmith: Advisor/Consultant|GlaxoKlineSmith: Grant/Research Support|Pfizer: Grant/Research Support|Vir: Advisor/Consultant Janet A. Englund, MD, Abbvie: Advisor/Consultant|AstraZeneca: Advisor/Consultant|AstraZeneca: Grant/Research Support|GlaxoSmithKline: Advisor/Consultant|GlaxoSmithKline: Grant/Research Support|Meissa Vaccines: Advisor/Consultant|Merck: Advisor/Consultant|Pfizer: Board Member|Pfizer: Grant/Research Support|Pfizer: Speaker at meeting|SanofiPasteur: Advisor/Consultant|Shinogi: Advisor/Consultant Michael J. Boeckh, MD PhD, Allovir: Advisor/Consultant|Allovir: Grant/Research Support|AstraZeneca: Advisor/Consultant|AstraZeneca: Grant/Research Support|Merck: Advisor/Consultant|Merck: Grant/Research Support|Moderna: Advisor/Consultant|Moderna: Grant/Research Support|Symbio: Advisor/Consultant